Search Results - luce+mattio

1 Results

Sort By:

Treatment for Metabolic Syndrome and Obesity Related Diseases

Background Abdominal obesity is the most commonly observed component of metabolic syndrome and a major risk factor for type II diabetes and cardiovascular disease. In addition to obesity, an individual’s risk of cardiovascular disease and type II diabetes is strongly correlated to a series of risk factors, collectively referred to as metabolic...

Published: 8/4/2022 | Inventor(s): Jan Frederik Stevens, Paul Blakemore, Ines Paraiso, Luce Mattio

Keywords(s): Chemical Synthesis, medicinal, Metabolic syndrome, Obesity, pharmaceuticals, Type 2 Diabetes

Category(s): Therapeutics